Literature DB >> 22868011

Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis?

Amanullah Abbasi1, Abdul Rabb Bhutto, Nazish Butt, Keshav Lal, S M Munir.   

Abstract

OBJECTIVE: To determine the association of serum cholesterol levels with Child-Pugh class in patients with decompensated chronic liver disease due to viral hepatitis. STUDY
DESIGN: Cross-sectional analytical study. PLACE AND DURATION OF STUDY: Jinnah Postgraduate Medical Centre, Karachi, Medical Unit-III, Ward-7 from June to December 2010.
METHODOLOGY: Consecutive patients attending outpatient department or admitted in medical unit III were eligible if they had a diagnosis of cirrhosis secondary to viral hepatitis. Patients were excluded if alcoholic, diabetic, hypertensive, or with non-alcoholic fatty liver disease, autoimmune, metabolic, cardiovascular, cerebrovascular or kidney diseases and recent use of lipid-regulating drugs. Serum lipid profile was determined after an overnight fast of 12 hours. On the basis of serum total cholesterol, patients were divided into four groups; Group I with serum total cholesterol ² 100 mg/dl, Group II with level of 101-150 mg/dl, Group III with level of 151-200 mg/dl and Group IV with serum total cholesterol level of > 200 mg/dl. Hepatic dysfunction was categorized according to Child-Pugh scoring system. Chi-square and Spearman's correlation testing with p < 0.05 was accepted as significant.
RESULTS: One hundred and fourteen patients met the inclusion criteria with a mean age of 40.32 ± 13.59 years. Among these 32 were females (28.1%) while 82 were males (71.9%). According to Child-Pugh class; 34 patients (29.8%) presented with Child-Pugh class A, 34 (29.8%) in class B and 46 (40.4%) were in class C. Serum cholesterol (total) and triglycerides had significant association with Child-Pugh class (p = 0.0001 and p = 0.004 respectively) suggesting that as severity of liver dysfunction increases; serum cholesterol and triglycerides levels decrease. Results also revealed that males were significantly more hypocholesterolemic than females (p = 0.006).
CONCLUSION: Hypocholesterolemia is a common finding in decompensated chronic liver disease and has got significant association with Child-Pugh class. It may increase the reliability of Child-Pugh classification in assessment of severity and prognosis in chronic liver disease patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868011     DOI: 08.2012/JCPSP.484487

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Lipid profile in cirrhotic patients and its relation to clinical outcome.

Authors:  Laura Boemeke; Lilian Bassani; Cláudio Augusto Marroni; Catarina Bertaso Andreatta Gottschall
Journal:  Arq Bras Cir Dig       Date:  2015 Apr-Jun

3.  Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients.

Authors:  Sadia Qamar Arain; Farah Naz Talpur; Naseem Aslam Channa; Muhammad Shahbaz Ali; Hassan Imran Afridi
Journal:  Lipids Health Dis       Date:  2017-03-01       Impact factor: 3.876

4.  The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.

Authors:  Gabriella A Raffa; Diana M Byrnes; John J Byrnes
Journal:  Case Rep Hematol       Date:  2021-03-26

5.  Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats.

Authors:  Masaki Ishikawa; Kosuke Saito; Hiroshi Yamada; Noriyuki Nakatsu; Keiko Maekawa; Yoshiro Saito
Journal:  Lipids Health Dis       Date:  2016-04-12       Impact factor: 3.876

6.  Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices.

Authors:  Amr Shaaban Hanafy; Mohamed Abdel Khalik Basha; Fady Maher Wadea
Journal:  World J Hepatol       Date:  2020-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.